Lung Cancer Clinical Trials

A listing of Lung Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1916 clinical trials
A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients

with locally advanced, unresectable, non-small cell lung cancer (Stage III), who have not progressed following definitive, platinum-based, chemoradiation therapy.

lung carcinoma
chemoradiotherapy
durvalumab
  • 284 views
  • 15 Jun, 2021
  • 147 locations
KN046 in Subjects With Advanced Squamous Non-small Cell Lung Cancer

This study is a randomized, double-blind, multicenter, phase III clinical study to compare the clinical efficacy and safety of KN046 plus paclitaxel and carboplatin versus placebo plus paclitaxel and carboplatin in subjects with advanced squamous NSCLC who have not previously received systemic treatment.

  • 0 views
  • 26 Jan, 2021
  • 1 location
Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr

Non Small Cell lung cancer (NSCLC) remains the first cause of death by cancer in the World. For the patients presenting a NSCLC stage IV, the median of survival is about 15 months today. The

metastasis
nivolumab
pd-l1
tumor cells
ipilimumab
  • 22 views
  • 25 Jan, 2021
  • 46 locations
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

) mutation (Exon 19 deletions [Exon 19del] or Exon 21 L858R substitution) positive, locally advanced or metastatic non-small cell lung cancer (NSCLC).

measurable disease
epidermal growth factor
stage iv non-small cell lung cancer
osimertinib
cancer treatment
  • 27 views
  • 02 Aug, 2021
  • 326 locations
Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

-small cell lung cancer compared to the combination of paclitaxel and carboplatin alone

carboplatin
stage iv non-small cell lung cancer
paclitaxel
  • 10 views
  • 07 Nov, 2020
  • 1 location
Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy

The purpose of this study is to improve early detection of treatable relapse of lung cancer and thereby improve survival and quality of life for the patients. The investigators will perform a

cancer chemotherapy
lung carcinoma
liquid biopsy
ct scan
adjuvant chemotherapy
  • 0 views
  • 26 Jan, 2021
  • 3 locations
Durvalumab vs Placebo With Stereotactic Body Radiation Therapy in Early Stage Unresected Non-small Cell Lung Cancer Patients

This is a Phase III, randomized, placebo-controlled, double-blind, multi-center study assessing the efficacy and safety of durvalumab with SoC SBRT versus placebo with SoC SBRT in patients with unresected clinical Stage I/II lymph node-negative (T1 to T3N0M0) NSCLC.

durvalumab
stereotactic body radiation therapy
lung carcinoma
  • 68 views
  • 28 Apr, 2021
  • 227 locations
A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer

-small cell lung cancer (NSCLC) with documented advanced or metastatic epidermal growth factor receptor (EGFR) mutation (Phase 1b expansion cohorts A, B and C), to estimate the antitumor activity of

platinum-based chemotherapy
epidermal growth factor
erlotinib
carboplatin
cancer chemotherapy
  • 5 views
  • 04 Aug, 2021
  • 87 locations
Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations

placebo as first line treatment for locally advanced or metastatic non-small cell lung cancer (NSCLC) patients with MET exon 14 skipping (METex14) mutations

metastasis
measurable disease
stage iv non-small cell lung cancer
EGFR
lung carcinoma
  • 1 views
  • 03 Aug, 2021
  • 21 locations
A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy Compared With Carboplatin-Pemetrexed in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions

chemotherapy alone in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) characterized by EGFR Exon 20ins mutations.

measurable disease
epidermal growth factor
pemetrexed
carboplatin
cancer chemotherapy
  • 0 views
  • 29 Jul, 2021
  • 282 locations